Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capri Holdings
CPRI
|
+$448M |
| 2 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$248M |
| 3 |
AGN
Allergan Inc
AGN
|
+$240M |
| 4 |
Apple
AAPL
|
+$223M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$677M |
| 2 |
Intuitive Surgical
ISRG
|
+$501M |
| 3 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$476M |
| 4 |
Crown Castle
CCI
|
+$365M |
| 5 |
Ralph Lauren
RL
|
+$336M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.28% |
| 2 | Consumer Discretionary | 14.62% |
| 3 | Technology | 10.39% |
| 4 | Communication Services | 9.8% |
| 5 | Energy | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLUE
451
DELISTED
bluebird bio
BLUE
| $16.3M | 0.02% |
+46,769
| New | +$17.4M |
|
452
McEwen Inc
MUX
$1B
| $16M | 0.02% |
668,134
+20,474
| +3% | +$464K |
|
|
DSCI
453
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $15.7M | 0.02% |
1,264,462
-3,585
| -0.3% | -$49.6K |
|
|
SGMO
454
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $15.6M | 0.02% |
+1,486,498
| New | +$14.8M |
|
|
ANDV
455
DELISTED
Andeavor
ANDV
| $15.5M | 0.02% |
352,625
+60,767
| +21% | +$3.03M |
|
456
Exelixis
EXEL
$13.9B
| $15.2M | 0.02% |
+2,618,530
| New | +$13.6M |
|
|
RALY
457
DELISTED
RALLY SOFTWARE DEV CORP
RALY
| $15.1M | 0.02% |
+504,401
| New | +$13.9M |
|
458
Woodward
WWD
$23B
| $14.2M | 0.01% |
348,077
-487,457
| -58% | -$20M |
|
|
VIAB
459
DELISTED
Viacom Inc. Class B
VIAB
| $14M | 0.01% |
168,084
-567,797
| -77% | -$43.9M |
|
|
IPXL
460
DELISTED
Impax Laboratories, Inc.
IPXL
| $13.7M | 0.01% |
667,488
-192,497
| -22% | -$3.97M |
|
|
DFRG
461
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
| $13.3M | 0.01% |
+658,482
| New | +$13.5M |
|
|
CMO
462
DELISTED
Capstead Mortgage Corp.
CMO
| $13.2M | 0.01% |
1,125,549
-266,753
| -19% | -$3.16M |
|
|
ENDP
463
DELISTED
Endo International plc
ENDP
| $13.2M | 0.01% |
290,204
-5,523
| -2% | -$222K |
|
|
ORBC
464
DELISTED
ORBCOMM, Inc.
ORBC
| $12.9M | 0.01% |
2,438,650
-96,465
| -4% | -$468K |
|
|
FCSC
465
DELISTED
Fibrocell Science Inc.
FCSC
| $12.7M | 0.01% |
+193,951
| New | +$15.7M |
|
466
Fastenal
FAST
$54.8B
| $12.6M | 0.01% |
+999,736
| New | +$11.8M |
|
467
American Eagle Outfitters
AEO
$2.94B
| $12.2M | 0.01% |
873,876
-21,724
| -2% | -$364K |
|
|
TEAR
468
DELISTED
TearLab Corporation
TEAR
| $12.1M | 0.01% |
109,601
+60,725
| +124% | +$7.57M |
|
469
Douglas Emmett
DEI
$2.05B
| $12.1M | 0.01% |
514,478
-18,380
| -3% | -$447K |
|
|
MLU
470
DELISTED
METLIFE, INC. COM EQUITY UNIT
MLU
| $11.8M | 0.01% |
413,000
-236,113
| -36% | -$8.22M |
|
471
Fortress Biotech
FBIO
$111M
| $11.5M | 0.01% |
109,660
+27,649
| +34% | +$3.39M |
|
|
PWE
472
DELISTED
Penn West Energy Petroleum Ltd
PWE
| $11.1M | 0.01% |
+1,000,967
| New | +$11.6M |
|
|
INFN
473
DELISTED
Infinera Corporation Common Stock
INFN
| $11M | 0.01% |
+974,406
| New | +$10.7M |
|
|
SGNT
474
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $11M | 0.01% |
539,823
-9,834
| -2% | -$219K |
|
|
TTPH
475
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $10.5M | 0.01% |
46,074
+499
| +1% | +$87.2K |
|
Similar funds
Jennison Associates's Q3 2013 Portfolio in Review
As of Q3 2013, Jennison Associates held 756 positions worth $95.4B, up 7.3% from $88.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Jennison Associates withdrew a net $3.46B in Q3 2013, closing 76 positions and reducing 326 holdings. Its most notable exit was Intuitive Surgical, an estimated $501M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Jennison Associates opened a new position in Under Armour worth $157M.
- Jennison Associates's largest Q3 2013 buy was Under Armour: 7,942,523 shares worth $157M.
- Jennison Associates added most to Capri Holdings in Q3 2013, an estimated $448M increase.
- Jennison Associates's biggest Q3 2013 reduction was IBM, cutting an estimated $677M.
- Jennison Associates fully exited Intuitive Surgical in Q3 2013, selling an estimated $501M.
- Jennison Associates's ten largest holdings make up 19% of its $95.4B portfolio in Q3 2013.
- Jennison Associates opened 84 new positions and closed 76 in Q3 2013.
- Jennison Associates's portfolio value rose 7.3% quarter-over-quarter to $95.4B.
Based on Jennison Associates's 13F filing for Q3 2013, filed 13 Nov 2013.